e-learning
resources
Barcelona 2010
Wednesday, 22.09.2010
New aspects of treatment of lower respiratory tract infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects and modulation of release rate of inhaled ciprofloxacin with liposomal formulations in healthy subjects and patients with bronchiectasis
P. Bruinenberg, D. Serisier, J. Blanchard, D. Cipolla, I. Gonda (Hayward, United States Of America; Brisbane, Australia)
Source:
Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections
Session:
New aspects of treatment of lower respiratory tract infections
Session type:
Oral Presentation
Number:
5574
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Bruinenberg, D. Serisier, J. Blanchard, D. Cipolla, I. Gonda (Hayward, United States Of America; Brisbane, Australia). Effects and modulation of release rate of inhaled ciprofloxacin with liposomal formulations in healthy subjects and patients with bronchiectasis. Eur Respir J 2010; 36: Suppl. 54, 5574
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Pharmacokinetics and antibacterial activity of inhaled liposomal ciprofloxacin hydrochloride in healthy volunteers and in cystic fibrosis (CF) patients
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009
Comparison of systemic bioavailability of two formulations of budesonide nebulized suspension in healthy subjects
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009
Comparison of pulmonary and systemic absoption of two HFA formulations of salmeterol in healthy subjects
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010
Comparison of the effectiveness of azithromycin and budesonide versus theophylline and budesonide in the suppression of pro-inflammatory cytokines in patients with COPD
Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2020
Inhaled liposomal ciprofloxacin hydrochloride significantly reduces sputum
pseudomonas aeruginosa
density in non-CF bronchiectasis
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies
Source: Eur Respir J, 56 (4) 2000110; 10.1183/13993003.00110-2020
Year: 2020
Effects of long acting β2-agonist, sustained-release theophylline and their combination on exercise parameters in asthmatic patients
Source: Eur Respir J 2002; 20: Suppl. 38, 287s
Year: 2002
Effects of atorvastatin in asthmatic patients under treatment with high dose inhaled or oral steroid
Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease
Year: 2010
Effects on adrenal function of a new combination of fluticasone propionate/formoterol fumarate administered to asthmatic patients and healthy subjects
Source: Annual Congress 2011 - Airways disease comorbidities and general aspects
Year: 2011
A multicompartmemt lung model predicts pulmonary pharmacokinetics of inhaled liposomal treprostinil (L606) in healthy volunteer
Source: Virtual Congress 2021 – Therapy of pulmonary hypertension
Year: 2021
Effect of inhaled tiotropium on tracheobronchial clearance in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 245s
Year: 2001
A placebo-controlled study of liposomal amikacin for inhalation nebulized once daily in the treatment of bronchiectasis patients with chronic
pseudomonas aeruginosa
lung infection
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009
Long term treatment with azithromycin tablets or extended release forms in patients with bronchiectasis
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
The pharmacokinetics of inhaled NVA237 in COPD patients
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010
Effect of azithromycin treatment on inflammation in COPD patients
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019
Distribution of nebulised gentamicin in patients with bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004
Pharmacokinetics and pharmacodynamics of ciclesonide and its active principle after inhalative and intravenous administration in healthy subjects
Source: Eur Respir J 2002; 20: Suppl. 38, 110s
Year: 2002
Effect of oral guaifenesin (Mucinex 1200mg) on mucociliary clearance from the lungs of healthy non-smoking adults
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010
Dry powder inhaled ribavirin in healthy volunteers: safety, tolerability, lung and systemic pharmacokinetics
Source: International Congress 2017 – From microbiology to clinical work
Year: 2017
Effect of omeprazol on pulmonary function test in asthmatic patients
Source: Eur Respir J 2006; 28: Suppl. 50, 316s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept